{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:48:34Z","timestamp":1786996114946,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.radonc.2023.109645","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T13:02:25Z","timestamp":1680008545000},"page":"109645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Protocol letter: Intra-treatment Image Guided Adaptive Radiotherapy Dose-escalation Study (InGReS) \u2013 A Phase 1 multicentre feasibility study"],"prefix":"10.1016","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1921-5437","authenticated-orcid":false,"given":"Delali","family":"Adjogatse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriana","family":"Michaelidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Sanchez Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kozarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Sassoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mererid","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rackley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorcha","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah-May","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Petkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Reis-Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally Fiona","family":"Barrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Guerrero Urbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109645_b0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1470-2045(09)70023-3","article-title":"Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data","volume":"10","author":"Michiels","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0010","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1200\/JCO.2014.58.6412","article-title":"Refining American Joint Committee on Cancer\/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas","volume":"33","author":"Huang","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/hed.21613","article-title":"Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery","volume":"34","author":"Takes","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2023.109645_b0020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/jso.23724","article-title":"Current treatment of head and neck squamous cell cancer","volume":"110","author":"Belcher","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0025","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.ejca.2015.07.043","article-title":"Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study","volume":"51","author":"Gatta","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2023.109645_b0030","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.oraloncology.2015.08.004","article-title":"Analysis of loco-regional failures in head and neck cancer after radical radiation therapy","volume":"51","author":"De Felice","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1748-717X-6-54","article-title":"Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy","volume":"6","author":"Oksuz","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archotol.132.1.67","article-title":"Complications in head and neck surgery: a meta-analysis of postlaryngectomy pharyngocutaneous fistula","volume":"132","author":"Paydarfar","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2023.109645_b0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.anl.2014.10.002","article-title":"Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy","volume":"42","author":"Leon","year":"2015","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.radonc.2023.109645_b0050","doi-asserted-by":"crossref","unstructured":"Bentzen SM. Radiobiological considerations in the design of clinical trials. Radiotherapy and Oncology. 1994;32:1\u20131.","DOI":"10.1016\/0167-8140(94)90443-X"},{"key":"10.1016\/j.radonc.2023.109645_b0055","first-page":"1045","article-title":"Adaptive dose painting by numbers for head-and-neck cancer. International Journal of Radiation Oncology* Biology*","volume":"80","author":"Duprez","year":"2011","journal-title":"Physics"},{"key":"10.1016\/j.radonc.2023.109645_b0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.radonc.2020.10.039","article-title":"18F-FDG-PET in guided dose-painting with intensity modulated radiotherapy in oropharyngeal tumours: A phase I study (FiGaRO)","volume":"1","author":"Michaelidou","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.radonc.2016.03.005","article-title":"Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer","volume":"120","author":"Rasmussen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ejca.2021.05.021","article-title":"Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trial","volume":"1","author":"Nutting","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2023.109645_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41199-019-0046-z","article-title":"Adaptive radiotherapy for head and neck cancer","volume":"5","author":"Morgan","year":"2020","journal-title":"Cancers Head Neck"},{"key":"10.1016\/j.radonc.2023.109645_b0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2008.05.021","article-title":"Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers","volume":"89","author":"Soto","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.radonc.2017.07.017","article-title":"Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions","volume":"124","author":"Mohamed","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0090","doi-asserted-by":"crossref","unstructured":"Subesinghe M, Scarsbrook AF, Sourbron S, Wilson DJ, McDermott G, Speight R, et al. Alterations in anatomic and functional imaging parameters with repeated FDG PET-CT and MRI during radiotherapy for head and neck cancer: a pilot study. BMC Cancer. 2015;15:1\u20131.","DOI":"10.1186\/s12885-015-1154-8"},{"key":"10.1016\/j.radonc.2023.109645_b0095","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00259-017-3890-2","article-title":"Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer","volume":"45","author":"Wong","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2023.109645_b0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/1754-9485.12439","article-title":"18F-FDG PET\u2013CT performed before and during radiation therapy of head and neck squamous cell carcinoma: Are they independent or complementary to each other?","volume":"60","author":"Min","year":"2016","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/1754-9485.12496","article-title":"A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy","volume":"61","author":"Min","year":"2017","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0110","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ijrobp.2020.04.030","article-title":"Single-center prospective trial investigating the feasibility of serial FDG-PET guided adaptive radiation therapy for head and neck cancer","volume":"108","author":"Gouw","year":"2020","journal-title":"Int J Radiat Oncol* Biol* Phys"},{"key":"10.1016\/j.radonc.2023.109645_b0115","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1186\/s12885-015-1867-8","article-title":"Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma","volume":"15","author":"Bird","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2023.109645_b0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0125","doi-asserted-by":"crossref","first-page":"20160624","DOI":"10.1259\/bjr.20160624","article-title":"Anatomic and dosimetric changes in patients with head and neck cancer treated with an integrated MRI-tri-60Co teletherapy device","volume":"89","author":"Raghavan","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2023.109645_b0130","first-page":"11","article-title":"Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT","volume":"1","author":"Mohamed","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.radonc.2013.01.003","article-title":"FDG-PET and diffusion-weighted MRI in head-and-neck cancer patients: implications for dose painting","volume":"106","author":"Houweling","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrclinonc.2016.162","article-title":"Imaging biomarker roadmap for cancer studies","volume":"14","author":"O'Connor","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) 92\u201304","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109645_b0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2006.03.009","article-title":"Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck","volume":"79","author":"Gr\u00e9goire","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2003.09.011","article-title":"CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines","volume":"69","author":"Gr\u00e9goire","year":"2003","journal-title":"Radiotherapy Oncol"},{"key":"10.1016\/j.radonc.2023.109645_b0160","doi-asserted-by":"crossref","unstructured":"Mir R, et al. Organ at risk delineation for clinical trials: A Global Harmonization Group consensus guideline. National Radiotherapy Trials Quality Assurance (RTTQA) Group. Forthcoming 2020.","DOI":"10.1016\/j.radonc.2020.05.038"},{"key":"10.1016\/j.radonc.2023.109645_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-016-2813-0","article-title":"DARS: a phase III randomised multicentre study of dysphagia-optimised intensity-modulated radiotherapy (Do-IMRT) versus standard intensity-modulated radiotherapy (S-IMRT) in head and neck cancer","volume":"16","author":"Petkar","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2023.109645_b0170","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1541-0420.2005.00311.x","article-title":"Continuous toxicity monitoring in phase II trials in oncology","volume":"61","author":"Ivanova","year":"2005","journal-title":"Biometrics"},{"key":"10.1016\/j.radonc.2023.109645_b0175","unstructured":"Continuous monitoring for toxicity using Pocock-type boundary. http:\/\/cancer.unc.edu\/biostatistics\/program\/ivanova\/ContinuosMonitoringForToxicity.aspx. Accessed March 2023."},{"key":"10.1016\/j.radonc.2023.109645_b0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.radonc.2015.03.014","article-title":"PET\/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014","volume":"116","author":"Konert","year":"2015","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023001834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023001834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:29:24Z","timestamp":1759123764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023001834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":36,"alternative-id":["S0167814023001834"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109645","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol letter: Intra-treatment Image Guided Adaptive Radiotherapy Dose-escalation Study (InGReS) \u2013 A Phase 1 multicentre feasibility study","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109645"}}